The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment

[1]  Z. Ben-Rafael,et al.  Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG , 1991, Journal of in Vitro Fertilization and Embryo Transfer.

[2]  I. Ben-Shlomo,et al.  Ovarian stimulation with gonadotropin-releasing hormone (GnRH) analogue improves the in vitro fertilization (IVF) pregnancy rate with both transvaginal and laparoscopic oocyte recovery , 1990, Journal of in Vitro Fertilization and Embryo Transfer.

[3]  T. Bjøro,et al.  Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders. , 1990, Human reproduction.

[4]  M. Davies,et al.  The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles. , 1989, Human reproduction.

[5]  P. Barlow,et al.  Fertility prognosis in IVF treatment of patients with cancelled cycles. , 1989, Human reproduction.

[6]  F. Bonilla-musoles,et al.  Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? , 1989, Human reproduction.

[7]  R. Frydman,et al.  Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone. , 1989, Human reproduction.

[8]  R. Frydman,et al.  Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation , 1988, Fertility and sterility.

[9]  S. Muasher.  Stimulation Protocols for Patients with “Atypical Response” , 1988, Annals of the New York Academy of Sciences.

[10]  R. Edwards,et al.  Short term use of an LHRH agonist to treat poor responders entering an in-vitro fertilization programme. , 1987, Human reproduction.

[11]  B. Tarlatzis,et al.  The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer. , 1984, Fertility and sterility.

[12]  L. Veeck,et al.  The importance of the follicular phase to success and failure in in vitro fertilization. , 1983, Fertility and sterility.

[13]  C Wood,et al.  Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. , 1981, Science.

[14]  R. Fleming,et al.  Correlation of ultrasonic and endocrinologic assessment of human follicular development. , 1979, American journal of obstetrics and gynecology.

[15]  G. Kunz,et al.  Influence of the duration of the oestradiol rise on the success rate in GnRH analogue/HMG-stimulated IVF cycles. , 1990, Human reproduction.

[16]  L. Dalprà,et al.  IVF: induction of ovulation in poor responders. , 1989, Journal of steroid biochemistry.

[17]  R. Frydman,et al.  Utilization of GnRH agonists for poor responders in an IVF programme. , 1989, Human reproduction.

[18]  R. Marrs,et al.  An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog. , 1988, Fertility and sterility.

[19]  D. Serr,et al.  Periovulatory 17 beta-estradiol changes and embryo morphologic features in conception and nonconceptional cycles after human in vitro fertilization. , 1986, Fertility and sterility.

[20]  E. Rudak,et al.  Periovulatory 17β-estradiol changes and embryo morphologic features in conception and nonconceptional cycles after human in vitro fertilization , 1986 .